ENOB Market Cap History



Below is a table of the ENOB market cap history going back to 11/13/2018:

Date ENOB Market Cap
11/13/2018278.54M
12/10/2018303.86M
2/12/2019309.93M
5/16/2019204.03M
7/15/20191.05B
9/27/2019196.66M
10/28/2019275.33M
11/13/2019256.36M
2/10/2020187.55M
5/11/2020191.57M
9/23/2020166.49M
11/12/2020142.71M
2/16/2021203.47M
5/17/2021174.93M
9/24/2021384.34M
10/28/2021464.23M
11/15/2021547.26M
2/14/2022394.75M
5/12/2022338.35M
3/9/202359.60M
5/12/202367.61M

Also see: ENOB Shares Outstanding History
and ENOB YTD Return
ENOB Historical Market Cap:
-27.03% CAGR
ENOB Historical Market Cap: +-27.03% CAGR

Mouse over chart for data details
11/13/2018 ...5/12/2023
Enochian BioSciences is a pre-clinical stage biotechnology company. Co.'s product candidates include: ENOB-HV-01 for autologous Human Immunodeficiency Virus (HIV) curative treatment; ENOB-HV-11 for preventive HIV vaccine; ENOB-HV-12 for therapeutic HIV vaccine; ENOB-HV-21 for HIV natural killer and gamma delta T-cell treatment or cure; ENOB-HV-31 for in vivo gene therapy; ENOB-HB-01 for hijacking Hepatitis B Virus polymerase; ENOB-CV-01 for coronavirus treatment; ENOB-CV-11 for coronavirus prophylaxis; ENOB-FL-01 for influenza treatment; ENOB-FL-11 for influenza prophylaxis; and ENOB-DC-11 for off the shelf dendritic cell vaccine for multiple solid tumors. We show 21 historical shares outstanding datapoints in our ENOB shares outstanding history coverage, used to compute ENOB market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ENOB market cap history over the course of time is important for investors interested in comparing ENOB's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ENOB versus a peer is one thing; comparing ENOB market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ENOB can fluctuate over the course of history. With this page we aim to empower investors researching ENOB by allowing them to research the ENOB market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ENOB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Enochian Biosciences (ENOB) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ENOV Market Cap History
ENSG Market Cap History
ENTA Market Cap History
ENVB Market Cap History
ENZ Market Cap History
EOLS Market Cap History
EPZM Market Cap History
EQ Market Cap History
ERAS Market Cap History
ERNA Market Cap History
More Healthcare companies »

 

ENOB Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.